Blue Water Biotech, Inc. announced an agreement with Knipper Health, Inc. to manage the inventory and distribution of product samples to sales representatives for ENTADFI and ZONTIVITY. Knipper Health has more than 35 years of experience building and maintaining operations for healthcare clients, including sample management, custom pharmacy solutions and 3PL services. As part of Blue Water?s product roll-out plans, Knipper Health will oversee sample inventory and ship samples on request to the sales force in the field.

This will help to expedite physicians? initiation of therapy for their patients while increasing familiarity with the products. Blue Water purchased ENTADFI in April 2023, followed by an asset purchase agreement for six FDA-approved assets, including ZONTIVITY, that is expected to close later this year.

Since the execution of those agreements, the Company has made significant commercialization progress with market access and distribution. Blue Water has executed agreements that cover market access and payor coverage, marketing and advertising, telehealth services generation and sales force development.